SLC9A1 and diabetes mellitus: Except for SGLT and late-INa inhibition, according to experimental studies, SGLT2is reduce intracellular Na+ by inhibiting sodium-hydrogen exchanger 1 (NHE-1), reversing calcium overload regardless of diabetes status [60].